Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Intangibles (2016 - 2025)

Historic Intangibles for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to $21.1 million.

  • Sanara MedTech's Intangibles fell 4979.49% to $21.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.1 million, marking a year-over-year decrease of 4979.49%. This contributed to the annual value of $23.5 million for FY2024, which is 4773.39% down from last year.
  • As of Q3 2025, Sanara MedTech's Intangibles stood at $21.1 million, which was down 4979.49% from $41.0 million recorded in Q2 2025.
  • Over the past 5 years, Sanara MedTech's Intangibles peaked at $46.0 million during Q3 2023, and registered a low of $4.7 million during Q1 2021.
  • Its 5-year average for Intangibles is $27.5 million, with a median of $30.8 million in 2023.
  • In the last 5 years, Sanara MedTech's Intangibles skyrocketed by 56645.9% in 2022 and then tumbled by 4979.49% in 2025.
  • Sanara MedTech's Intangibles (Quarter) stood at $4.7 million in 2021, then skyrocketed by 566.46% to $31.5 million in 2022, then skyrocketed by 42.58% to $44.9 million in 2023, then plummeted by 47.73% to $23.5 million in 2024, then decreased by 10.14% to $21.1 million in 2025.
  • Its last three reported values are $21.1 million in Q3 2025, $41.0 million for Q2 2025, and $42.0 million during Q1 2025.